Cargando…
Withaferin A Inhibits Prostate Carcinogenesis in a PTEN-deficient Mouse Model of Prostate Cancer()()
We recently demonstrated that AKT activation plays a role in prostate cancer progression and inhibits the pro-apoptotic function of FOXO3a and Par-4. AKT inhibition and Par-4 induction suppressed prostate cancer progression in preclinical models. Here, we investigate the chemopreventive effect of th...
Autores principales: | Moselhy, Jim, Suman, Suman, Alghamdi, Mohammed, Chandarasekharan, Balaji, Das, Trinath P., Houda, Alatassi, Ankem, Murali, Damodaran, Chendil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421823/ https://www.ncbi.nlm.nih.gov/pubmed/28494348 http://dx.doi.org/10.1016/j.neo.2017.04.005 |
Ejemplares similares
-
Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model
por: Suman, Suman, et al.
Publicado: (2016) -
Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells
por: Suman, Suman, et al.
Publicado: (2016) -
Inhibition of autophagy prevents cadmium-induced prostate carcinogenesis
por: Pal, Deeksha, et al.
Publicado: (2017) -
Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancer
por: Das, Trinath P., et al.
Publicado: (2016) -
Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer
por: Das, T P, et al.
Publicado: (2016)